Premium
Pharmacological Approaches to Managing Migraine and Associated Comorbidities—Clinical Considerations for Monotherapy Versus Polytherapy
Author(s) -
Silberstein Stephen D.,
Dodick David,
Freitag Fred,
Pearlman Starr H.,
Hahn Steven R.,
Scher Ann I.,
Lipton Richard B.
Publication year - 2007
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.2007.00760.x
Subject(s) - migraine , comorbidity , medicine , depression (economics) , anxiety , psychiatry , population , concomitant , epilepsy , triptans , intensive care medicine , environmental health , economics , macroeconomics
Comorbidity is defined as an illness that occurs more frequently in association with a specific disorder than would be found as a coincidental association in the general population. Conditions that are frequently comorbid with migraine include depression, anxiety, stroke, epilepsy, sleep disorders, and other pain disorders. In addition, many common illnesses occur concomitantly (at the same time) with migraine and influence the treatment choice. Migraine management, and especially migraine prevention, can be challenging when patients have comorbid or concomitant illnesses. The objectives of this initiative are to review the literature on managing patients who have migraine and common comorbidities, present additional clinical approaches for care of these difficult patients, and evaluate the areas in which research is needed to establish evidence‐based guidelines for the management of migraine with associated comorbid conditions.